U.S. market Closed. Opens in 7 hours 52 minutes

PMN | ProMIS Neurosciences, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.0800 - 1.1676
52 Week Range 0.9200 - 3.10
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 32,424
Average Volume 70,325
Shares Outstanding 29,885,452
Market Cap 32,276,288
Sector Healthcare
Industry Biotechnology
IPO Date 2007-01-10
Valuation
Profitability
Growth
Health
P/E Ratio -2.00
Forward P/E Ratio N/A
EPS -0.54
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 6
Country Canada
Website PMN
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
*Chart delayed
Analyzing fundamentals for PMN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see PMN Fundamentals page.

Watching at PMN technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on PMN Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙